arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Olema Pharmaceuticals, Inc.

OLMA

$12.04 ▲ +0.23 (+1.95%) at close

27 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Olema Pharmaceuticals, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -9.5% ↘

FCF / Share $-0.45

Trailing P/E —

Price / Book 2.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-53.09M

↓ -74.7% —

FCF / Share Free cash flow per share

$-0.45

↑ +13.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	-44.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-27.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	18.3% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	5.6% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	35.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-10.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	20.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	26.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	15.8% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	40.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-20.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-18.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-26.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-95.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	N/M	87.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	55.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-74.7% Weak ↓ Weak Declining Year-over-year change in net income	-37.2% Weak ↓ Weak Declining Year-over-year change in net income	-22.2% Weak → Weak Stable Year-over-year change in net income	-44.1% Weak ↓ Weak Declining Year-over-year change in net income	1.9% Caution ↑ Caution Improving Year-over-year change in net income	-25.4% Weak ↑ Weak Improving Year-over-year change in net income	-60.7% Weak ↓ Weak Declining Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	-9.5% Weak ↓ Weak Declining Year-over-year change in net income	-2.3% Weak ↓ Weak Declining Year-over-year change in net income	5.4% Fair ↑ Fair Improving Year-over-year change in net income	38.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-22.8% Weak ↑ Weak Improving Year-over-year change in net income	-21.0% Weak ↑ Weak Improving Year-over-year change in net income	-28.3% Weak ↑ Weak Improving Year-over-year change in net income	-100.3% Weak → Weak Stable Year-over-year change in net income	-50.1% Weak ↑ Weak Improving Year-over-year change in net income	-113.6% Weak ↑ Weak Improving Year-over-year change in net income	-125.8% Weak ↑ Weak Improving Year-over-year change in net income	-568.8% Weak Weak Year-over-year change in net income	-806.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	13.1% Fair Fair Year-over-year change in free cash flow	—	—	—	-21.0% Weak Weak Year-over-year change in free cash flow	—	—	—	15.8% Good Good Year-over-year change in free cash flow	—	—	—	-12.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.45x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.27x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-9.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	27.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	7.1% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-3.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-11.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-9.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-7.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-8.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-17.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-13.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-13.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-10.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-7.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-12.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-16.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-13.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-10.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-7.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-5.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-4.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	34.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+128%)	17.6% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+17%)	14.5% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1.60x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-52.55M	$-48.30M	$-35.26M	$-52.47M	$-50.64M	$-139.48M	$-35.89M	$-16.89M	$-33.72M	$-68.54M	$-117.41M	$-34.96M	$-40.92M	$-23.70M	$-26.80M	$-24.53M	$-21.51M	$-13.81M	$-25.60M	$-50.42M	$-47.88M	$-338.55M	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.52	$-0.51	$-0.49	$-0.51	$-0.36	$-0.40	$-0.60	$-0.54	$-0.56	$-0.48	$-0.48	$-0.49	$-0.70	$-0.65	$-0.57	$-0.82	$-0.58	$-0.55	$-0.45	$-0.42	—	$1.87	$-3.71	$-0.95	—	—	—
Free Cash Flow per Share (USD)	$-0.45	—	$-0.40	$-0.35	$-0.51	—	—	—	$-0.43	—	—	—	$-0.51	—	—	—	$-0.45	—	—	—	—	—	$-2.88	$-0.46	—	—	—
Book Value per Share (USD)	$5.50	$5.88	$4.48	$5.03	$5.61	$5.50	$3.47	$3.97	$4.23	$4.62	$5.04	$3.93	$4.33	$4.90	$5.43	$5.91	$6.65	$7.15	$7.58	$7.94	$8.29	$8.60	$-8.77	$-5.38	—	—	—
Tangible Book Value per Share (USD)	$5.50	$5.88	$4.48	$5.03	$5.61	$5.50	$3.47	$3.97	$4.23	$4.62	$5.04	$3.93	$4.33	$4.90	$5.43	$5.91	$6.65	$7.15	$7.58	$7.94	$8.29	$8.60	$-8.77	$-5.38	—	—	—
Basic Weighted Avg Shares (shares)	102.80M	—	85.73M	85.50M	85.43M	—	57.26M	56.28M	55.57M	—	44.98M	40.72M	40.35M	—	40.04M	39.92M	39.83M	—	39.61M	39.42M	—	—	2.62M	2.59M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$466.06M	$463.65M	$292.67M	$334.56M	$370.60M	$396.71M	$187.29M	$215.65M	$225.87M	$244.89M	$266.04M	$156.68M	$169.99M	$192.35M	$212.51M	$230.72M	$260.05M	$281.67M	$299.38M	$312.71M	$324.99M	$337.55M	—	—	—	—	—
Total Equity (USD)	$480.48M	$478.56M	$307.49M	$345.24M	$383.45M	$408.96M	$198.91M	$227.16M	$236.32M	$253.90M	$275.13M	$161.58M	$174.97M	$197.55M	$217.70M	$236.28M	$265.09M	$284.57M	$300.89M	$314.08M	$326.02M	$338.14M	$-22.96M	$-13.95M	$-11.65M	$-10.59M	$-8.40M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Depreciation Expense (USD)	$119.00K	$187.00K	$43.00K	$132.00K	$128.00K	$116.00K	—	—	$88.00K	$88.00K	—	—	$100.00K	$97.00K	—	—	$84.00K	$73.00K	—	—	$9.00K	$4.00K	$2.00K	$2.00K	$3.00K	—	—
Net Income, GAAP (USD)	$-53.09M	$-46.06M	$-42.22M	$-43.78M	$-30.39M	$-33.57M	$-34.55M	$-30.38M	$-30.97M	$-26.77M	$-21.50M	$-20.09M	$-28.29M	$-26.18M	$-22.72M	$-32.86M	$-23.03M	$-21.64M	$-17.71M	$-16.41M	$-15.34M	$-10.13M	$-7.84M	$-2.45M	$-1.69M	—	—
Operating Cash Flow (USD)	$-45.99M	$-38.33M	$-34.53M	$-29.88M	$-43.98M	$-26.28M	—	—	$-23.50M	$-18.48M	—	—	$-20.39M	$-19.71M	—	—	$-17.90M	$-18.60M	—	—	$-11.08M	$-9.01M	$-7.54M	$-1.18M	$-2.14M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 27 quarters

Olema Pharmaceuticals, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OLMA with peers